Summary
Does the use of a restricted drug formulary achieve cost savings within state Medicaid programmes? Restricted formularies are often justified by putting forth the attributes of a perfectly operating and implicitly costless policy. Analysis suggests, however, that the operation of ‘actual’ restricted formularies produce realised effects that are substantially at odds with the desired effects. Although the implementation of a restricted formulary can reduce a state’s drug expenditures, service substitution causes expenditures to increase elsewhere in the system. Furthermore, direct savings in the drug budget are completely offset by these spillover effects.
Similar content being viewed by others
References
Demsetz H. Information and efficiency: another viewpoint. Journal of Law and Economics XII: 1–22, 1966
Dranove D. Medicaid drug formulary restrictions. Journal of Law and Economics 33: 143–162, 1989
Jang R. Medicaid formularies: a critical review of the literature. Journal of Pharmaceutical Marketing and Management 2 (3): 39–61, 1988
Moore WJ, Newman RJ. Drug formulary restrictions as a costcontainment policy in Medicaid programs. Department of Economics Working Paper, Louisiana State University, 1991
National Pharmaceutical Council (NPC). Pharmaceutical Benefits UnderState Medical Assistance Programs, September 1990
Reeder EC, Lingle EW. An evaluation of the South Carolina Medicaid open formulary system. Final report submitted National Pharmaceutical Council, Inc., Washington, DC, 1988
Rucker D, Schit TG. Drug formularies: myths—in—formation. Medical Care 28: 928–939, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, W.J., Newman, R.J. US Medicaid Drug Formularies. Pharmacoeconomics 1 (Suppl 1), 28–31 (1992). https://doi.org/10.2165/00019053-199200011-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199200011-00008